Abstract 13163: Clonal Hematopoiesis Risk Score is Associated With All-Cause and Cardiovascular Mortality in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study

Seyedmohammad Saadatagah,Mesbah Uddin,Lachelle D Weeks,Abhishek Niroula,Meng Ru,Koichi Takahashi,Steven Bradley,Bing Yu,Alexander G Bick,Benjamin L Ebert,Elizabeth A Platz,Pradeep Natarajan,Christie M Ballantyne,Md Mesbah Uddin

DOI: https://doi.org/10.1161/circ.148.suppl_1.13163

IF: 37.8

2023-11-07

Circulation

Abstract:Introduction: Clonal hematopoiesis of indeterminate potential (CHIP) is common in older adults, but the prognostic significance is unknown. We studied the prevalence of CHIP and its mortality in older adults and investigated whether the CHIP risk score (CHRS) -tool to predict hematologic malignancies (HM)- is associated with mortality in this population. Method: In ARIC cohort, CHIP was identified using exome sequencing, and CHRS scores were calculated using demographic, blood parameters, and molecular features. Individuals with CHIP were categorized into low- (CHRS≤9.5), intermediate- (9.5<CHRS<12.5), and high-risk (CHRS ≥12.5) groups. The primary outcome was all-cause death, and secondary outcomes were death from HM and cardiovascular disease (CVD). Results: In 3871 participants without a history of HM (aged 75.7 ± 5.2 years, 58.5% female, 23.1% Black), we identified 938 (24.2%) with CHIP, of whom 562 (59.9%) were low risk, 318 (33.9%) intermediate risk, and 58 (6.2%) high risk by the CHRS. During a median follow-up of 7.13 years, 570 (19.4%) deaths occurred in participants without CHIP and 128 (22.8%), 93 (29.2%), and 33 (56.9%), in the CHRS groups, respectively. Using multivariable competing risk regression, the hazard ratio HR (95% confidence interval) for all-cause mortality was 1.09 (0.90-1.32, P = 0.35), 1.13 (0.90-1.42, P = 0.29), 2.57 (1.75-3.77, P <0.001), for low-, intermediate-, and high-risk CHIP, respectively. ( Fig. 1A ) Compared to those without CHIP, in the high-risk CHIP, the HR of death from HM (6 deaths of 58, 10.3%) was 25.92 (8.04-83.57, P <0.001) and from CVD (12 of 58, 20.7%) was 2.97 (1.59-5.53, P <0.001). ( Fig. 1B ). Conclusions: CHIP can be identified in one-fourth of older adults, and most were low-risk and had the same survival. However, individuals with high-risk CHIP face not only an elevated risk of death from HM but also a threefold higher risk of death from CVD. The latter was the most common cause of death in this group. Funding: NHLBI, NCI, NPCR

cardiac & cardiovascular systems,peripheral vascular disease